ArticleOncology2024

Analysis of Risk Factors for Febrile Neutropenia in Patients with Small-Cell Lung Cancer Receiving Carboplatin Plus Etoposide Therapy.

Masaya Takahashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.